Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

PRP shows promise for treating female hair loss but needs more research.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

PRP is promising for skin, hair, and wound treatments but needs standardized methods and more research.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

New understanding and treatments for hair loss are improving, but more research is needed.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Thiopurines help treat IBD but require genetic testing to avoid side effects.